Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate their condition. Unlike childhood asthma, which often receives immediate ...
An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. African American patients gained less from the digital intervention. The study ...
Please provide your email address to receive an email when new articles are posted on . Data were derived from Silberman J, et al. JAMA Netw Open. 2025;doi:10.1001 ...
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.
In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...
Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.
Asthma in older age is associated with other comorbidities, according to a study published in the Journal of Asthma and ...
A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...
Please provide your email address to receive an email when new articles are posted on . Maternal asthma raises the risk for various perinatal complications. Asthma exacerbations during pregnancy are ...
Washington, DC, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) applauds Congress for protecting $33.5 million in funding for the Centers for Disease Control and ...
Dupilumab was linked to improved lung function, asthma control, QOL, and biomarkers for up to 2 years in patients with uncontrolled severe asthma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results